echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Study on the mechanism of RESISTANCE of MET inhibitors by GBM

    Study on the mechanism of RESISTANCE of MET inhibitors by GBM

    • Last Update: 2020-06-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Nichola Cruickshanks, of the University of Virginia's Immunology and Cancer Biology, and others studied the drug resistance mechanisms of MET inhibitors in GBM and developed new ways to overcome themThe findings were published in the January 2019 issue of Clinical Cancer Research- From the articleRef:Cruickshanks N,et al.
    Clin Cancer Res.
     2019 Jan 15;25 (2):663-673doi: 10.1158/1078-0432.CCR-18-0926Epub 2018 Sep 10.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.